Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.

MapLight Therapeutics is a clinical-stage biopharma focused on CNS disorders and has filed for a $100M U.S. IPO to fund its ...

Ocrevus subcutaneous maintains consistent benefit-risk profile after two years -- New late-breaking data confirms Ocrevus ...

ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS) following switch to Kesimpta after ...

Objective Youth with childhood-onset SLE (cSLE) have increased risk of serious infection. It is unknown how much of this risk ...

This article was originally published by Uncloseted Media.By Spencer MacNaughton, Sam Donndelinger, Taya StraussIn the United ...

SKNY transaction strengthens MIRA pipeline with SKNY-1, a differentiated oral candidate that has demonstrated up to 30% ...

A perfectly preserved dinosaur embryo has been found in China: little Yingliang reveals the posture of birds before birth.

In this article, ACRO explores multiple sclerosis—a silent battle unfolding within the central nervous system.

Is nearing full enrollment for its NEO100-01 Phase 2a trial, with top-line data readout anticipated in early 2026. The final patient cohort in its NEO212 Phase I trial is also on track for completion ...

In Japan, primary care physicians are frequently presented with alcohol use disorder (AUD) co-occurring with other ...

Complex Regional Pain Syndrome (CRPS), a neurological disorder affecting the central and peripheral nervous systems, ...